Company intelligence / Profile preview

Hebei Finis Biotechnology

Shijiazhuang, Hebei, China

Ownership: Private
Development stage: Other

Overview

Hebei Finis Biotechnology is a specialized biotechnology and chemical manufacturing company based in Shijiazhuang, China. The firm focuses on the production and supply of high-purity pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and research peptides. Their product portfolio prominently features metabolic health compounds such as semaglutide and tirzepatide, as well as various steroid hormones and custom-synthesized peptides. Hebei Finis Biotechnology operates primarily as a contract manufacturer and global exporter, supporting pharmaceutical research and development through large-scale chemical synthesis.

Therapeutic areas: EndocrinologyMen's Health
Modalities: PeptidesBiologicSmall molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Hebei Finis Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Finis Biotechnology.

Explore the full profile